Designing Inhibitors for the SARS CoV Main Protease as Anti-SARS Drugs
Severe Acute Respiratory Syndrome (SARS) is a serious respiratory illness reported in parts of Asia and Canada. A novel coronavirus (CoV) has been isolated and identified as the cause of the SARS for which there is currently no effective treatment. Given the epidemic, the rapid development of effica...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
McGill University
2020-12-01
|
| Series: | McGill Journal of Medicine |
| Subjects: | |
| Online Access: | https://mjm.mcgill.ca/article/view/377 |